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Abstract
Background: The functional components of bone marrow (i.e., the hematopoietic and stromal populations) and the
adjacent bone have traditionally been evaluated incompletely as distinct entities rather than the integrated system. We
perturbed this system in vivo using a medically relevant radiation model in the presence or absence of ovarian function to
understand integrated tissue interaction.
Methodology/Principal Findings: Ovary-intact and ovariectomized mice underwent either no radiation or single fractional
16 Gy radiation to the caudal skeleton (I6R, OVX6R). Marrow fat, hematopoietic cellularity, and cancellous bone volume
fraction (BV/TV %) were assessed. Ovariectomy alone did not significantly reduce marrow cellularity in non-irradiated mice
(OVX2R vs. I2R, p = 0.8445) after 30 days; however it impaired the hematopoietic recovery of marrow following radiation
exposure (OVX+R vs. I+R, p = 0.0092). The combination of radiation and OVX dramatically increases marrow fat compared to
either factor alone (p = 0.0062). The synergistic effect was also apparent in the reduction of hematopoietic marrow cellularity
(p = 0.0661); however it was absent in BV/TV% changes (p = 0.2520). The expected inverse relationship between marrow
adiposity vs. hematopoietic cellularity and bone volume was observed. Interestingly compared with OVX mice, intact mice
demonstrated double the reduction in hematopoietic cellularity and a tenfold greater degree of bone loss for a given unit of
expansion in marrow fat.
Conclusions/Significance: Ovariectomy prior to delivery of a clinically-relevant focal radiation exposure in mice,
exacerbated post-radiation adipose accumulation in the marrow space but blunted bone loss and hematopoietic
suppression. In the normally coupled homeostatic relationship between the bone and marrow domains, OVX appears to
alter feedback mechanisms. Confirmation of this non-linear phenomenon (presumably due to differential radiosensitivity)
and demonstration of the mechanism of action is needed to provide strategies to diminish the effect of radiation on
exposed tissues.
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Introduction
Radiation is a common treatment modality for almost all
cancers. However the impact of irradiation on normal bone and
bone marrow and their interactions are not well characterized,
despite the importance of understanding the complications of
treatment due to the increasing number of long-term cancer
survivors. Women in particular may experience accelerated bone
loss from anti-cancer therapy (e.g. chemotherapy, endocrine
therapy, radiation, chemo-radiation) [1], primarily due to the
varying status of the ovarian hormones. Women who undergo
cancer therapy experience a 10–20% increased fracture risk from
treatment-induced bone loss compared to healthy patients [2,3].
Furthermore, recovery from skeletal damage induced by radiation
in women with differing ovarian function (i.e., pre- and post-
menopausal) may have variable responses to anti-resorptive
therapy [4]. Thus, we hypothesize that damage and subsequent
recovery of the bone and bone marrow after irradiation may
depend on ovarian status. This clinical question highlights the
importance of fundamental biological investigations into the
relationships of bone, marrow components (hemopoietic marrow
measured by cellularity, stromal marrow measure by adiposity),
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and how they are impacted by physiological factors and the
treatment of disease.
In the past, bone and hematopoietic tissues have been
considered distinct entities, with bone merely providing a physical
scaffold for the hematopoietic precursors of the marrow. More
recent work emphasizes critical bidirectional biochemical and
mechanical communications through which bone metabolism and
hematopoiesis are linked [5,6]. This suggests that a more
integrated approach to the understanding of radiation-induced
injury to these tissues is necessary and emphasizes the interface
between basic biology and translational applications in clinical
medicine. Mesenchymal stromal cells (MSC) residing in the
marrow space give rise to cellular populations of the marrow
microenvironment, such as osteoblasts and adipocytes. Because of
their pluripotent capability, there has long been an assumption
MSC phenotype directly influences bone – related parameters,
i.e., increasing marrow adipogenesis is inversely proportional with
bone mass [7–10]. MSCs additionally act as key regulators of
hematopoiesis. There is evidence that MSC abnormalities
contribute to the pathology of hematopoietic diseases, such as
myelodysplastic syndrome [11]; that they may play a role in
hematopoietic recovery after radiation injury [12]; and that they
influence hematopoietic recovery after transplantation [13].
Given advancements in radiation therapy, including radiation-
based conditioning regimens for bone marrow transplantation, a
comprehensive evaluation of the effects on bone and marrow and
their interactions will be crucial for the optimization of therapeutic
protocols and the application of rational strategies for patient
management. In general, marrow adiposity is shown to be
negatively correlated to osteogenic potential [14–17]. These tissue
level interactions must be clarified if more in depth investigations
of molecular mechanisms are to be undertaken in terms of the
relevant biology of the system in disease states. In the current
study, we evaluated the effects of clinically relevant doses of
radiation on patterns of bone marrow changes in murine models
over time, and measured the influence of ovarian function on
radiation induced changes in hematopoiesis, adipogenesis and
bone mass.
Methods
Four groups of skeletally mature BALB/c female mice (16 weeks
old) were used for this study. The schematic representation of the
design of this study is described by Figure 1. The first experiment
characterized the response of the hematopoietic space to a
clinically relevant dose of radiation in intact female mice to
establish the kinetics of hematopoietic recovery in the presence of
normal ovarian function. The second experiment evaluated the
response of bone and hematopoietic marrow space 30 days after
radiation exposure in both ovary-intact (I) and ovariectomized
(OVX) mice, which were utilized to mimic the clinical manage-
ment of pre-menopausal and menopausal (spontaneous or
induced) cancer patients undergoing radiation therapy (R), with
appropriate controls. OVX mice were ovariectomized by the
vendor 57 days prior to irradiation (Jackson Laboratory; Bar
Harbor, ME). The day of radiation is designated Day 0. Mice were
randomly divided into the following groups: 1) ‘‘I2R’’ (intact no
radiation, n = 5, 5 and 7 sacrificed at day 3, 8 and 30; 2) ‘‘I+R’’
(intact irradiated, n = 5, 5 and 9 sacrificed at day 3, 8 and 30); 3)
‘‘OVX2R’’ (OVX no radiation, n = 7 sacrificed at day 30); and 4)
‘‘OVX+R’’ (OVX irradiated, n = 8 sacrificed at day 30). This
study was approved by the University of Minnesota Institutional
Animal Care and Use Committee (IACUC).
Animal Husbandry
Mice were weighed prior to irradiation and daily following
irradiation for 10 days, as well as prior to placement in metabolic
collection cages. Mice were housed 3–5 per cage, in a
temperature- and humidity-controlled room with free access to a
standard rodent chow containing 18.6% protein, 1% calcium, and
1.5 IU/g vitamin D3 (2018; Harlan Teklad, Madison, WI) and
water. Mice were acclimated to a 12-hour light/dark cycle. There
was small weight loss (0.5 to 1gm) in radiation group compared to
non-irradiated group as expected. This small change in body
weight however is not expected to affect the results of our study.
Radiation Delivery
Details of radiation delivery are described by our previous
publication [4]. Briefly, all mice in the I+R and OVX+R groups
were anesthetized using a 0.05 mL intraperitoneal injection of a
cocktail of 2.0 mL ketamine, 0.2 mL xylazine (100 mg/mL), and
1.8 mL sterile saline. All mice in the I2R and OVX2R groups
were also anesthetized to control for the possible impact of
anesthesia. A 16 Gy (single fraction) radiation was delivered in
mice at the hind limb by a Philips RT250 orthovoltage unit. A
specially designed lead shield was used to limit radiation to only
the hind limbs. Proper placement of shielding was confirmed using
Kodak EDR-2 film and total dose delivered was verified using
micro thermo-luminescent dosimeters (micro-TLD).
Ovariectomy verification
Wet uterine weights of mice from the I6R and OVX6R
groups were measured immediately post-mortem to verify efficacy
of vendor-performed ovariectomy surgeries. Ovary-intact mice
had a median wet uterine weight of 0.057 g, which was
significantly greater than that of 0.014 g for ovariectomized mice
(Wilcoxon rank-sum test, p = 0.0003).
MicroCT
Bone microarchitecture of mice was analyzed with a microCT
Scanner (mCT 35, Cone-Beam microCT, Scanco Medical,
Switzerland). The distal femoral metaphysis was scanned within
a region of 0.3–1.0 mm from the growth plate in order to avoid
the primary spongiosa, with a slice thickness of 7 mm resolution
(100 slices) at 70 kVp. Using the manufacturer’s software,
cancellous bone regions of interest (ROIs) were drawn (see
Figure 1. Experimental Plan Schematic. Sixteen week old BALB/c
mice were ovariectomized (OVX) and maintained in the vivarium for 57
days in order to attain skeletal hemostasis. Both intact (I) and OVX mice
were then irradiated with 16Gy delivered to the caudal skeleton or
maintained as controls. Groups of animals were euthanized at 3, 8, and
30 days post irradiation in order to perform histological evaluations of
the distal femur; microCT measurements were conducted at the 30 day
time point only.
doi:10.1371/journal.pone.0042668.g001
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Figure 2 A). The cancellous bone is composed of trabecular bone
matrix and marrow. The cancellous bone volume fraction (BV/
TV %; i.e. the ratio of the segmented trabecular bone volume to
the total tissue volume of the region of interest) of the ROI was
estimated.
Histology
The left hind limb of each mouse was dissected. Following mCT
scanning, the distal femur was collected, fixed in 10% formalin for
24 h, decalcified in Immunocal (a mild formic acid solution; Decal
Corp, Tallman, NY) at 4uC until soft, processed and embedded in
paraffin wax. Paraffin sections of 4 mm thick were mounted on
glass slides for histological analysis. Complete sagittal sections of
mouse femur were stained with hematoxylin and eosin (H&E) and
were evaluated using standard procedures by a board certified
veterinary clinical pathologist experienced in bone marrow
evaluation (LS) [18–20]. Briefly, the hemopoietic cellularity
(abbreviated as cellularity for the remainder of the manuscript)
of the hematopoietic space was visually estimated and scored as a
percentage of the total two dimensional area. The numbers of
megakaryocytes were estimated as normal, mildly decreased,
decreased, or markedly decreased. The ratio of myeloid to
erythroid precursors (M:E ratio) was scored as normal, mildly
increased, increased, or markedly increased. If the overall
cellularity was #5%, the numbers of hematopoietic precursors
were considered too low to accurately estimate the M:E ratio and
no estimate was undertaken. Figure 2 illustrates congestion,
sinusoidal dilation, and edema that were observed transiently after
radiation (2B), as well as variations in hematopoietic cellularity and
% adipose tissue observed on day 30 of the protocol (2C).
The maturation of hematopoietic precursors was assessed as
normal or left shifted (i.e., less differentiated), indicating an
abnormal number of relatively immature precursors relative to
more mature forms. If the overall cellularity was #5%, the
progression of maturation could not be accurately assessed and no
evaluation was conducted. The presence of morphologic abnor-
malities including sinusoidal dilation, edema, congestion, inflam-
mation, necrosis, fibrosis, vasculitis and increased hemosiderin was
indicated as follows: 0 indicating abnormality was absent, 1+ mild,
2+ moderate, 3+ marked and 4+ severe changes. Endosteal lining
cells were classified as normal or plump (i.e., activated).
Marrow fat measurement
The number and percent adipocyte area (as a percentage of
field) were determined from a histological section scan by a single
observer using Adobe Photoshop CS5 (version 12.0.4). Reported
values were then averaged for each treatment group.
Statistical Analysis
For ovary-intact mice, two-way ANOVA with Tukey’s post tests
was used to evaluate the effects of radiation, time and their
interaction on bone marrow hematopoietic cellularity. Megakar-
yocyte, myeloid: erythroid ratio, sinusoidal dilation, congestion
and edema were analyzed using Kruskal-Wallis test for the
comparisons across three time points in each of the I-R and I+R
arms, and Wilcoxon rank-sum test for the comparisons between
two time points in the same arm and between non-irradiated and
irradiated arms at the same time point.
Comparisons between ovary-intact and ovariectomized mice
were limited to Day 30 because ovariectomized mice had been
measured for that time-point only. Wilcoxon rank-sum test was
used for the comparisons between radiation treatments for the
same type of mice and between different types of mice given the
same radiation treatment for megakaryocyte, myeloid:erythroid
ratio, congestion and fibrosis.
To understand the interrelationships between hematopoiesis,
adipogenesis and bone, two-factor multivariate analysis of variance
(MANOVA) was conducted for Day 30 hematopoietic cellularity,
marrow fat, and BV/TV. Factors including ovary status, radiation
exposure, and their interaction were considered in the MANOVA
model. Correlation between every two tissue components was
evaluated by partial correlation coefficient. Following the
MANOVA, two-way ANOVA was performed for individual tissue
components and Tukey’s post tests were used for multiple
comparisons.
For Kruskal-Wallis and Wilcoxon rank-sum tests, unadjusted p
values are reported and subject to adjustment by Bonferroni’s
method. For Tukey’s post tests, adjusted p values are reported. All
the analyses were conducted using SAS 9.2 (SAS Institute Inc.,
Cary, NC, USA).
Results
Time course of the hematopoietic response to radiation
in intact female mice
In ovary-intact mice, we established that exposure to radiation
resulted in marked hypocellularity of the hematopoietic compo-
nents of the marrow by Day 3 (mean = 3.2%), with considerable
recovery but still very low hematopoietic activity on Day 8
(mean = 12.8%, p = 0.0292 when comparing to Day 3) and
marked but still incomplete recovery of hematopoietic activity
with normal precursor maturation at Day 30 (mean = 72%,
p,0.0001 when comparing to both Day3 and Day 8) (See
Figure 3). Over the same time course, there was no change in
hematopoietic cellularity in the I2R mice (mean = 95.4%, 94.6%
and 96.2% for Day 3, 8 and 30, respectively) (Figure 3). As
expected, megakaryocyte numbers were significantly depressed
by radiation exposure on Days 3 (median scale =23) and 8
Figure 2. Schematic representation of bone and marrow. A.
region of interest in sagittal view of a normal control mouse. B. Sagittal
section of bone marrow from an intact mouse 8 days post-irradiation.
Note the areas of congestion and sinusoidal dilation characterized by
increased density of red blood cell within the expanded vascular spaces;
also present are areas of edema characterized by increased volume of
pale pink fluid in the interstitial spaces. C. Sagittal sections of bone
marrow 30 days after irradiation in intact (C1) and OVX (C2) mice. Note
the more intensely purple areas indicative of higher hematopoietic
activity in C1 compared with C2, as well as expanded adipose in C2
compared with C1.
doi:10.1371/journal.pone.0042668.g002
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(median scale =23), with a trend towards ongoing suppression
on Day 30 (median scale =21) (Table 1). Although too few
hematopoietic precursors were available for interpretation in the
markedly hypocellular Day 3 post-irradiation marrow, the
recovery phase was accompanied by significantly increased
myeloid to erythroid ratios (median scale = 2 on Day 8 and = 1
on Day 30) characterized by persistent erythroid hypoplasia
(Table 1). Radiation resulted in concurrent vascular abnormal-
ities in the marrow space, including moderate to marked
sinusoidal dilation and venous congestion that were mostly
resolved by Day 30, and transient edema on Day 8 (Table 2).
Endosteal lining cells were transiently plump in 4/5 mice on Day
3 only. Increased hemosiderin (iron pigment) was observed in 3/5
irradiated mice and fibrosis in 2/5 irradiated mice on Day 30
only. These changes were not associated with evidence of
inflammation in the marrow space.
Hematopoietic response to radiation and OVX on day 30
post-irradiation
Radiation significantly decreased hematopoietic cellularity in
intact mice (p = 0.0002), however it resulted in more severe
suppression of hematopoietic cellularity in OVX mice (p,0.0001).
The interaction between radiation and ovarian function was close
to significance (F = 3.93, p = 0.0661) (See Table 3). Effects were
similar on megakaryocytes: radiation exposure significantly
decreased megakaryocyte numbers for both ovary-intact and
OVX mice (p = 0.0450 and 0.0217, respectively), but the effect
was exacerbated by absence of ovarian hormones (I+R vs.
OVX+R, p = 0.0255) (Table 4). The myeloid to erythroid ratio
was increased due to erythroid hypoplasia in irradiated mice
regardless of hormonal status (p = 0.0236 and 0.0182) (Table 4).
There was mild residual congestion due to irradiation in ovary-
intact mice (p = 0.0495), but this was not observed in OVX mice
(p = 0.1336). Irradiation-induced mild fibrosis was observed in
OVX mice (p = 0.0143) but not in ovary-intact mice (p = 0.1336).
Ovarian hormones did not play a significant role on the
development of congestion and fibrosis with or without irradiation
(p = 0.2207–1.0000 respectively) (Table 5).
Impact of radiation and OVX on marrow fat and
cancellous bone on day 30
Radiation did not significantly increase the marrow adipose
content of intact mice (p = 0.1203), however radiation did
significantly increase marrow adipose in OVX mice (p,0.0001).
OVX significantly increased marrow adipose content in the
absence of radiation (p = 0.0132) and with radiation (p,0.0001)
(See Table 3). Correspondingly, the interaction between OVX and
radiation significantly influenced marrow adipose level (F = 10.14,
p = 0.0062). On the other hand, radiation alone significantly
reduced BV/TV% (p = 0.0467), but OVX had no additive effects
on BV/TV % (OVX*radiation interaction, F = 1.42, p = 0.2520).
Collectively, radiation caused a disproportionate increase in
marrow adiposity in OVX mice compared with intact animals,
but previous ovariectomy did not influence the effect of radiation
on BV/TV%, thus demonstrating a dissociation between the
regulation of marrow adipose content and bone volume.
Integration of hematopoiesis, adipogenesis, and bone
volume
Overall, hematopoietic cellularity and marrow fat content were
negatively correlated (partial correlation coefficient =20.30,
Figure 3. Percent of the marrow space (mean ±SEM) occupied by hematopoietic precursors in intact control (I2R) and irradiated
(I+R) mice estimated by visual inspection by a board certified veterinary clinical pathologist (LS) employing standard protocols.
Radiation caused marked hypocellularity of the hematopoietic components of the marrow by Day 3, with significant increases but still very low
hematopoietic activity on Day 8 and marked but still incomplete recovery of hematopoietic activity with normal precursor maturation at Day 30.
There were no changes over time in non-irradiated animals. Two-way ANOVA with Tukey’s post-tests: * Irradiated mice had significantly lower
cellularity than control mice of the same day, p,0.0001, { Cellularity of irradiated mice increased significantly from Day 3 through Day 30, p: 0.0292 –
,0.0001.
doi:10.1371/journal.pone.0042668.g003
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p = 0.2616), hematopoietic cellularity and BV/TV% were
positively correlated (partial correlation coefficient = 0.12,
p = 0.6587), and marrow fat and BV/TV% were negatively
correlated (partial correlation coefficient =20.13, p = 0.6328),
however, none of these correlations achieved statistical signifi-
cance.
To help understand the effect of radiation in the presence or
absence of ovarian function on the interrelationships between
hematopoiesis, adipogenesis, and bone, we calculated radiation-
induced changes in each tissue relative to the other two
components for ovary-intact and OVX mice based on Figure 4.
First we calculated the differences in least squares means of the
three tissue components between non-irradiated and irradiated
mice in the ovary intact and OVX groups, respectively. Then we
calculated the following 3 ratios for each ovarian function group:
difference of % BV/TV over that of % marrow fat, difference of
% hematopoietic cellularity over that of % marrow fat, and
difference of % BV/TV over that of % hematopoietic cellularity.
Mathematically these ratios are the slopes of blue and red lines in
Figure 4. They indicate the amount of change in one tissue
component per unit change in another tissue component.
Specifically, intact mice demonstrate a 1.2% reduction in bone
volume for every % increase in marrow adipose after radiation.
OVX mice only demonstrate a 0.1% decrease in bone volume for
every % increase in marrow adipose with radiation treatment.
This represents a ten-fold reduction in bone volume loss per %
increase in marrow fat when comparing OVX with intact mice
(Figure 4, Panel A). Intact mice demonstrate a 0.1% reduction in
bone volume for every 1% decrease in hematopoietic cellularity
after radiation, however OVX mice show only a 0.02% reduction
in bone volume for the same 1% loss of hematopoietic cellularity
after radiation. OVX appears to blunt the rate of bone volume loss
relative to reduced hematopoietic cellularity after radiation
treatment by a factor of 6 (Figure 4, Panel B). Collectively,
OVX seems to reduce the responsiveness of bone volume to
changes in marrow components, with a greater change in
sensitivity to adipose than hematopoiesis. Lastly, intact mice
demonstrate a 9.9% reduction in hematopoietic cellularity for
every 1% increase in marrow fat after radiation, while OVX
results in a 5.1% reduction in hematopoietic cellularity for every
1% increase in marrow fat, approximately a half of the radiation
effect for intact mice (Figure 4, Panel C).
Discussion/Conclusions
This study was designed to gain insight into the integrated
responses of bone and marrow in a laboratory rodent model of
Table 1.Megakaryocyte number and myeloid: erythroid ratio in intact control (I2R) and irradiated (I+R) mice estimated by a board
certified veterinary clinical pathologist (LS) according to standard protocols.
Treatment Day Megakaryocytes Myeloid:Erythroid ratio
Control 3 N N N N N N N N N N
8 N N N N N N N N N N
30 N N N N N N N N N N
Irradiated 3* 23 23 23 23 23 NA NA NA NA NA
8*{ 23 23 23 22 22 +2 +2 +2 +2 +2
30*{ 21 21 21 21 N +2 +2 +1 +1 +1
Cells contain the data for individual mice (n = 5/group); N =normal, NA= too few cells to reliably estimate. Numerical scale: 24 severely decreased, 23 markedly
decreased, 22 moderately decreased, 21 mildly decreased, +1 mildly increased, +2 moderately increased, +3 markedly increased, +4 severely increased, normal
assigned a value of 0 for statistical calculations. Megakaryocyte numbers were significantly depressed by radiation exposure on Days 3 and 8, with a trend towards
ongoing suppression on Day 30. Too few hematopoietic precursors were available for interpretation in the markedly hypocellular Day 3 post-irradiation marrow, but the
recovery phase was accompanied by significantly increased myeloid to erythroid ratios characterized by persistent erythroid hypoplasia. Wilcoxon rank-sum test:
*Megakaryocytes, Irradiated significantly decreased compared with Control of the same day, Day 3, p = 0.0182; Day 8, p = 0.0236; Day 30, p = 0.0450.
{Myeloid:Erythroid ratio, Irradiation significantly increased when compared with Control, Day8, p = 0.0182; Day 30, p = 0.0236.
doi:10.1371/journal.pone.0042668.t001
Table 2. Semi-quantitative assessment of vascular abnormalities in intact control (I2R) and irradiated (I+R) mice estimated by a
board certified veterinary clinical pathologist (LS) according to standard protocols.
Treatment Day Sinusoidal Dilation Congestion Edema
Control 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
30 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Irradiated 3*{ +3 +3 +2 +2 +2 +2 +2 +1 +1 +3 +1 0 0 0 0
8*{{ +2 +2 +2 +2 +2 +3 +2 +2 +2 +2 +2 +2 +1 +1 0
30 +1 +1 0 0 0 +1 +1 +1 0 0 0 0 0 0 0
Numerical scale: 0 not present, +1 mild, +2 moderate, +3 marked, +4 severe. Radiation caused moderate to marked sinusoidal dilation and venous congestion on days 3
and 8 that was mostly resolved by Day 30, and transient edema on Day 8. Wilcoxon rank-sum test:
*Irradiated (marginally) significantly greater sinusoidal dilation compared with control of the same day, Day 3, p = 0.0507; Day 8, p = 0.0182.
{Irradiated significantly greater vascular congestion compared with control of the same day, Day3, p = 0.0247; Day8, p = 0.0217.
{Irradiated marginally significantly greater edema compared with control of the same day, Day 8, p = 0.0507.
doi:10.1371/journal.pone.0042668.t002
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pre- and post-menopausal patients undergoing therapeutic radi-
ation. New research strongly supports bidirectional coregulation of
bone and marrow components at the micro-environmental level,
attesting to the importance of evaluating these tissues as an
integrated unit in order to advance our understanding of the
response to injury or physiologic change [5,21]. Our data
demonstrated early and transient severe hematopoietic depletion
and vascular pathology with later substantial but incomplete
recovery 30 days after local irradiation in intact female mice.
Furthermore, we showed that the proportionality of more chronic
changes post-irradiation among the three tissue components of
bone and marrow evaluated (hemopoietic, adipose, and osseous)
was distinctly different depending upon the presence or absence of
ovarian hormones. Multiple fold increases in the marrow fat
fraction due to irradiation were not reflected in equivalent loss of
either bone or hematopoietic cellularity in OVX compared with
intact mice. OVX appeared to predispose the MSC population
toward an adipogenic phenotype; radiation further enhanced
adipogenesis in an additive fashion without proportional gross
effects on the adjacent bone or hematopoietic cellularity.
As expected, irradiation in intact female mice resulted in
significant and persistent decreases in hematopoietic cellularity
activity of the bone marrow and increased marrow fat, although
subjectively there appeared to be sufficient residual hematopoietic
activity to support life in our study animals. These findings are
similar to previously reported studies using male Wistar rats [22],
which demonstrated early hematopoietic suppression coincident
with sinusoidal dilation, and expansion of adipose in the more
chronic phase (days 12–180). While specific proportional relation-
ships were not described in detail, the authors did observe that the
degree of hematopoietic recovery relative to the degree of
adipogenesis varied with the radiation protocol, suggesting that
the frequently observed inverse relationship of hematopoiesis and
adipogenesis in the marrow does not occur in fixed ratios in all
situations. Other studies in mice have specifically demonstrated
the detrimental effects of radiation on the in vitro proliferation of
both hematopoietic and stromal bone marrow precursor cell
populations that were detectable up to six months after explant of
marrow stromal cells into culture [23]. Teasing out the relative
impact of radiation damage to hematopoietic and mesenchymal
precursor cells is confounded by an inability to isolate subcom-
ponents within the complex matrix of the bone marrow
microenvironment [24]. In addition, repair of radiation damage
may be associated with migration of HSCs as well as MSCs from
non-IR treated sites [24,25], further complicating interpretation.
Due to our focus on tissue level interaction details in this
manuscript, we envision series of future work in this model
including mechanistic consideration for the expansion of adipose
in the damaged marrow.
The current study found that OVX alone did not significantly
reduce hematopoietic cellularity or bone volume while, while
marrow fat content was increased. Expansion of the marrow
adipose population is often associated with OVX in studies of rats
and mice [26–28]. However, these investigators also report
concurrent reductions in hematopoiesis or bone mineral density,
describing a reciprocal relationship between marrow fat and
hematopoiesis and bone. The degree of these changes is time
dependent [27], so time and other experimental variables such as
Table 3. Comparison of group least squares means (6 SEM) of hematopoietic cellularity, adiposity, and bone volume in intact (I)
and ovariectomized (OVX) mice without radiation (2R) and with radiation (+R) 30 days after radiation treatment.
Treatment group % Hematopoietic cellularity (SEM) % Adipose (SEM) %BV/TV (SEM)
I2R 96.2 (3.0)a 1.11 (0.72)a 5.61 (0.86)
I+R 72.0 (3.0)a,c 3.55 (0.72)b 2.63 (0.86)
OVX2R 93.0 (3.4)b 4.97 (0.81)a,c 4.53 (0.96)
OVX+R 56.0 (3.0)b,c 12.14 (0.72)b,c 3.66 (0.86)
Within columns, identical letters indicate relevant statistically significant differences between groups at p#0.001). Radiation significantly reduced hematopoietic
cellularity in intact mice, but the effect was more severe in OVX (interaction F = 4.79, p = 0.0439). OVX alone had no effect on hematopoietic activity in the absence of
radiation. Radiation significantly increased marrow adipose only in OVX (interaction F = 10.14, p = 0.0062), and OVX increased marrow fat without and with radiation
treatment. Radiation significantly reduced BV/TV% (p= 0.0467), but OVX had no additive effect. All statistical analyses were based on two-way ANOVA.
doi:10.1371/journal.pone.0042668.t003
Table 4.Megakaryocyte number and myeloid: erythroid ratio in intact (I) and ovariectomized (OVX) mice receiving either 0 (2R) or
16 Gy radiation (+R) 30 days previously.
Hormone status Radiation Megakaryocytes Myeloid:Erythroid ratio
Intact 0 0 0 0 0 0 0 0 0 0 0
16 Gy*{ 21 21 21 21 0 +1 +1 +1 +2 +2
OVX 0 0 0 0 0 0 0 0 0 0 0
16 Gy*{{ 22 22 22 22 23 +1 +1 +1 +1 +1
Semi-quantitative estimates performed by a board certified veterinary clinical pathologist (LS) according to standard protocols. Cells contain the data for individual mice
(n = 5/group). Numerical scale: 24 severely decreased, 23 markedly decreased, 22 moderately decreased, 21 mildly decreased, +1 mildly increased, +2 moderately
increased, +3 markedly increased, +4 severely increased, normal assigned a value of 0 for statistical calculations. Wilcoxon rank-sum test:
*Radiation exposure significantly decreased megakaryocyte numbers compared with non-irradiated in both intact and OVX mice (p = 0.0450 and 0.0217, respectively),
and
{OVX exacerbated the decrease in megakaryocytes after radiation exposure (I+R vs. OVX+R, p = 0.0255).
{Myeloid:erythroid ratio was increased by irradiation in both intact and OVX mice (p = 0.0236 and 0.0182, respectively).
doi:10.1371/journal.pone.0042668.t004
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age and species or strain may explain variations in the findings.
OVX may drive differentiation of the marrow stromal cells
towards adipocytes at the expense of osteoblasts, resulting in
diminished bone formation [28]. In contrast, other investigators
describe enhanced differentiation of marrow stromal cells towards
osteoblasts after OVX [29], but that bone loss is due to
simultaneous but more robust increased production or activity of
osteoclasts, which may actually be partially driven by the ability of
osteoblasts to support osteoclastogenesis [26,30,31]. Preliminary
histomorphometry in our laboratory indicate that OVX drives
down the percent of trabecular bone surface covered by
osteoblasts, though not to the same degree as irradiation with
16Gy (data not shown). In addition, we observed a significant
increase in osteoclast number following OVX. Some of the effects
of ovariectomy may be via canonical estrogen receptor effects on
gene transcription [30], however other mechanisms may be
mediated by inflammatory cells and cytokines [26,29,31]. The
mechanistic connection with expanding adipose may be the role of
fat in regulating inflammation via adipokines [26], as well as
opposing effects on fat and bone of key regulatory molecules such
as PPAR-c [32].
It should be noted that 30 days after irradiation was equal to 87
days post OVX in the present study (Figure 1). Since bone surfaces
are generally quiescent following ovariectomy with time [33],
marrow may be expected to respond to radiation to a greater
degree when compared with bone, since rapidly dividing cells are
more radiosensitive (demonstrated by Figures 3 and 4). Addition-
ally, the ovary intact animals may exhibit more tightly coordinated
interactions between the marrow milieu and the adjacent bone,
while the lack of ovarian hormones uncouples the two resulting in
disproportionate effects between these tissue envelopes as
illustrated by Figure 5. New evidence demonstrates more
independent regulation of bone and fat under some circumstances
[34]. Differential radiosensitivity of the constituent cell populations
should be investigated further by more extensive studies in bone
and isolated marrow cell survivability.
Our study corroborates the inverse relationship between
marrow adipose and bone described by others [32,35], however
most noticeably the stoichiometry of the association after radiation
therapy is altered significantly by hormonal status. We propose
complex interrelationships among the three tissue components of
bone and marrow evaluated (hemopoietic, adipose, and osseous)
and illustrated this in a multi-dimensional space (Figure 5). OVX
and radiation had synergistic effects in promoting marrow
adipogenesis and suppressing hematopoiesis. Given the reciprocal
relationship between marrow fat and bone, a similar decrement in
bone volume was anticipated, and this expectation was reinforced
by the disproportionate hematopoietic suppression since normal
osteoblastogenic signals from hematopoietic stem cells might be
blunted in this population [36]. Correspondingly, osteoblasts are
necessary to maintain the hematopoietic stem cell niche and
support hematopoiesis, suggesting that it is reasonable to expect
that the effects of radiation on hematopoiesis and bone would
closely mirror one another [12,37]. Disproportionate changes in
interacting tissue components will need to be further investigated
by additional studies with a larger sample size. In addition, cellular
and molecular studies are necessary to help understand how
ovariectomy influenced the response to radiation in this model.
The ability of OVX to disrupt expected relationships between
these tissues in response to radiation presents an opportunity to
expand the use of this model system to understand the
relationships between these closely linked tissues and has clinical
implications for the treatment of cancer patients.
Translational importance
Patients with gynecological cancer experience an accelerated
and distinct pattern of trabecular bone loss from systemic
chemotherapy and local pelvic radiation [1]. The murine model
described by this work simulates the effects of pelvic radiation
administered to pre- and post-menopausal women who have
endometrial or rectal cancers. Bone marrow is considered to be a
critical organ as Loren et al recently reported hematological
toxicity from pelvic radiation therapy treatment [38,39]. Different
radiation modalities such as fractionated radiation therapy and
total body radiation are responsible for increased commitment of
non-hematopoietic mesenchymal stromal cells towards marrow
adipogenesis as well as for increased bone resorption [40–42]. It
appears that radiation (and chemotherapy) perturbs the homeo-
stasis of bone and marrow by damaging each individual
compartment (bone, hemopoietic and non-hemopoietic). Interac-
tion of these components in presence of radiation with/without
ovariectomy is unknown and will begin to unfold through stepwise
increased investigations.
The experimental radiation dose is selected to be radiobiolog-
ically equivalent to the average prescribed clinical dose. A single
fraction 16 Gy is radiobiologically equivalent to high dose of
radiation that is given in 2Gy per fraction as hypo-fractionation.
Hypo-fractionation helps repairing critical organs which is the
basis of radiation therapy. Because a variety of fractionation
schema is used among clinical trials, Fowler suggested using the
normalized tumor dose (NTD) which is the biological effective
dose (BED), normalized to a 2Gy fraction. This is discussed in
details by Folwer et al extensively in their 2006 paper [43]. For late
normal-tissue complications, 16 Gy (single fraction) irradiation in
mice at the hind limb is approximately equivalent to 60 Gy (2 Gy/
fraction) radiation dosage delivered to patients in the pelvic region.
Table 5. Congestion and fibrosis in intact and ovariectomized (OVX) mice receiving either 0 or 16 Gy radiation 30 days previously.
Hormone status Radiation Congestion Fibrosis
Intact 0 0 0 0 0 0 0 0 0 0 0
16 Gy* +1 +1 +1 0 0 +1 +1 0 0 0
OVX 0 0 0 0 0 0 0 0 0 0 0
16 Gy{ +1 +1 0 0 0 +1 +1 +1 +1 0
Semi-quantitative estimates performed by a board certified veterinary clinical pathologist (LS) according to standard protocols. Cells contain the data for individual mice
(n = 5/group). Numerical scale: 24 severely decreased, 23 markedly decreased, 22 moderately decreased, 21 mildly decreased, +1 mildly increased, +2 moderately
increased, +3 markedly increased, +4 severely increased, normal assigned a value of 0 for statistical calculations. Wilcoxon rank-sum test:
*Radiation exposure significantly increased congestion compared with non-irradiated (p = 0.0495),
{Radiation significantly increased fibrosis compared with non-irradiated (p = 0.0143). Note that ovarian hormonal status did not separately affect either parameter.
doi:10.1371/journal.pone.0042668.t005
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Briefly, 16 Gy is equivalent to a BED of 101.3 Gy and a NTD of
60.8 Gy, and 60 Gy (2 Gy/fraction) is equivalent to a BED of 100
Gy and a NTD of 60 Gy [using Fowler method [43] assuming a/b
to be 3 Gy for late normal-tissue complications] [4]. Approxi-
mately 20% of the total murine skeleton (as measured by
posthumous dry bone weight) was exposed to radiation. This is
equal to the percent of total skeleton in the average irradiated
pelvic region (20–30% as measured by CT) of a clinical subject.
The areas of comparison between our murine model and clinical
subjects also have comparable amounts of total skeletal trabecular
bone volume. Therefore, as a simplified murine model, a one-time
exposure of 16 Gy can be used to accurately simulate clinical
irradiation of bone tissue.
Another aspect examined by the present study concerns ovarian
status. We have demonstrated that the presence of ovarian
hormones may modulate the severity of the radiation effect on
bone and marrow. Thus, in the clinic a patient’s ovarian status
may be important to the ultimate preservation of bone and bone
marrow integrity. As shown by Figure 5, the pre-menopausal
patient may be at a higher risk for skeletal damage following
clinical radiotherapy and should be more closely evaluated for
irradiation effects on the skeleton. Additionally, since marrow
cellularity (and presumably function) eventually recovers, hema-
topoietic response to treatment ought to be evaluated long-term.
Conclusions
Therapeutic radiation affects the pattern of bone and bone
marrow changes in different ways depending on the ovarian status
of the recipient. Radiation results in significant damage to marrow
cellularity though it recovers with time. The relationship between
marrow adipogenesis and bone loss appears dependent on ovarian
function, with the bone loss being greater for a given unit of
expansion in marrow fat in the presence than in the absence of
ovarian function. Understanding the extent and nature of changes
in bone marrow, bone remodeling and related skeletal damage will
be beneficial to optimizing potential interventions during or
following cancer therapy.
Figure 4. Ovariectomy influences the relationships between
bone volume (BV/TV%), adipogenesis (% marrow fat), and
hematopoiesis (% cellularity) at Day 30 with or without 16 Gy
radiation to the hind limb in mice. Data of every two
measurements are represented as least squares mean values for the
group. Panel A: OVX results in a 10 fold reduction in the rate of bone
volume loss per unit increase in marrow fat after radiation treatment
compared with intact mice. Panel B: OVX blunts the rate of bone
volume loss relative to reduced hematopoietic cellularity after radiation
compared with intact mice by a factor of 6. Panel C: OVX halves the
reduction in hematopoietic cellularity compared with increased marrow
fat after radiation treatment compared with intact mice.
doi:10.1371/journal.pone.0042668.g004
Figure 5. 3-D illustration of interrelationships among the three
tissue components of bone and marrow: hemopoietic compo-
nent measured by cellularity, stromal damage component
measured by marrow fat or adipose content, and osseous
component measured by the cancellous bone BV/TV%.
Cumulative increases in marrow fat after irradiation, in the absence of
ovarian function (10 fold) was not reflected by equivalent losses of
either cancellous bone or hematopoietic cellularity. The proportionality
of changes in these tissue components were maintained among
irradiated intact mice.
doi:10.1371/journal.pone.0042668.g005
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